Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Aberdare Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Aberdare Ventures

Aberdare Ventures

Operating

Aberdare Ventures: A California-based venture capital firm investing in transformative healthcare companies.

Location
San Francisco, CA, US
Founded
1999
Firm
Compare
Portfolio
Employees
Website

Investments

MC10
MC10

Total Raised

$97.4M

Rounds

12

Series Unknown$10MAugust 2018
Series C$10MDecember 2012
Series Unknown$2MJanuary 2012
Realeve
Realeve

Total Raised

$136.2M

Rounds

6

Series D$43.2MJune 2015
Series D$38MMay 2015
Series C$32MOctober 2011
Adavium Medical
Adavium Medical

Total Raised

$41M

Rounds

2

Private Equity$20MSeptember 2013
Aviir
Aviir

Total Raised

$69.9M

Rounds

13

Series B$10MJune 2013
Series B$10MFebruary 2013
Series Unknown$10MDecember 2011
Series Unknown$3MJune 2011
Series Unknown$4.2MJanuary 2010
Series Unknown$1MOctober 2009
Series Unknown$7.8MDecember 2008
Cervel Neurotech
Cervel Neurotech

Total Raised

$42.5M

Rounds

8

Series Unknown$14.1MApril 2013
Series A$1.5MSeptember 2008
RxAnte
RxAnte

Total Raised

$45.5M

Rounds

5

Series A$4.6MSeptember 2012
Viracta Therapeutics
Viracta Therapeutics
Public

Total Raised

$194.9M

Rounds

11

Series B$13MMarch 2012
Series B$12MApril 2010
Omada Health
Omada Health

Total Raised

$528.5M

Rounds

11

Seed$800kDecember 2011
Nevro
Nevro
Public

Total Raised

$555.8M

Rounds

8

Series B$58MJuly 2011
Series A$21.8MSeptember 2008
Posit Science
Posit Science

Total Raised

$24M

Rounds

5

Series Unknown$3.1MMarch 2011
Series Unknown$5.6MApril 2009
Clovis Oncology
Clovis Oncology
Public

Total Raised

$145M

Rounds

3

Series Unknown$145MMay 2009